Spring Sciences Australia - Medicinal Cannabis Producer

Categories Securities, Agribusiness
Sale Type Price on Application
Price Guide AUD $10M (A$20M Pre-Money Valuation)
Status: Open

Summary:

Spring Sciences Australia Signs Exclusive Deal with BOHECO For Full Product Line and R&D platform

Caboolture Medical Cannabis Grower Nearing First Harvest

Spring Sciences, an established US medicinal cannabis cultivator and manufacturer, has launched with its Australian partners, Spring Sciences Australia (SSA), an emerging player in the nascent and growing Australian medicinal cannabis market. SSA is progressing the first of two primary growth phases of its integrated Farm-to-Pharma business model; the construction of an advanced fully climate-controlled GACP/GMP certified cultivation and production facility.

The state-of-the-art 3000m2 grow facility is under construction in the Caboolture area and will supply flower and whole-of-plant oils, followed by infused medicinal products, to both the domestic Australian and key international markets. SSA will leverage the competitive advantages that an established North American cannabis producer brings to the sector in terms of IP transfer, ramp-up speed, quality and yield of production, and value-add product development capabilities, to outperform its market peers. SSA has been granted its medicinal cannabis cultivation and production licence MC064/20 as well as its medicinal cannabis manufacturing licence ML062/20 and will commence grow operations in Q4 2021.

 

Share this Listing

 

Go Back

 
Animoca Brands
PrimaryMarkets

VIEW OUR VIDEOS

Become a Follower